American Well Corp (AMWL): M&A transaction — Amwell sells telepsychiatry business to Avel eCare for $21M cash plus earn-out

American Well Corp

Upfront cash $20.7M (1.1x trailing 12-month revenue) plus earn-out of 0.4x next 12-month revenues.
Sale closed Jan 8; includes APC technology, personnel, Asana network. Reiterates FY2024 revenue guidance $247-252M.
Reiterates positive cash flow goal in 2026. Pro forma shows ~$24M annual revenue removed and ~$10.4M estimated gain on sale.
Pro forma for 9 months to Sep 30, 2024: net loss improved from $(165.5M) to $(164.0M), EPS from $(11.13) to $(11.03).

item 1.01 item 2.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

American Well Corp completed a disposition involving Avel eCare, LLC for $20,714,459 (closed 2025-01-08).

Action: disposition
Counterparty: Avel eCare, LLC
Consideration: $20,714,459
Closing: 2025-01-08

Exact text from the filing

contracts and the related accounts receivable and all accounts payable and accrued expenses of the Business. The purchase price is comprised of (i) an upfront cash payment of $20,714,459, which is equal to 1.1x the Business’ trailing twelve-month revenue, excluding on-site revenue attributable to certain of the Business’ contracts, subject to customary adjustments

View on SEC.gov

68 m&a transactions filed in the last 30 days. Browse all m&a transactions →

American Well Corp filing history →

Source: SEC EDGAR

accession 0000950170-25-004254

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.